PWP
IDXX icon

Personal Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Personal Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-95
Closed -$60K – 217
2021
Q2 		$60K Buy
+95
New +$52.5K 0.02% 147
2020
Q1 		– Sell
-195
Closed -$51K – 299
2019
Q4 		$51K Hold
195
– – 0.02% 143
2019
Q3 		$53K Buy
195
+5
+3% +$1.39K 0.02% 141
2019
Q2 		$52K Buy
+190
New +$46.8K 0.02% 129

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Personal Wealth Partners's IDXX Position: Q3 2021 in Review

Personal Wealth Partners sold out of Idexx Laboratories (IDXX) in Q3 2021, closing a stake of 95 shares — an estimated $60K sold.

Personal Wealth Partners first reported a position in IDXX in Q2 2019 and held it in 4 quarters. The position peaked at $60K in Q2 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

  • Personal Wealth Partners reported no remaining Idexx Laboratories position as of Q3 2021 after selling out during the quarter.
  • Personal Wealth Partners sold 95 Idexx Laboratories shares in Q3 2021, an estimated $60K.
  • Personal Wealth Partners first reported a position in Idexx Laboratories in Q2 2019 and held it in 4 quarters.
  • Personal Wealth Partners's Idexx Laboratories position peaked at $60K in Q2 2021.
  • 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on Personal Wealth Partners's 13F filing for Q3 2021, filed 20 Oct 2021.